Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Ovarian Neoplasms 7Small Cell Lung Carcinoma 6Fallopian Tube Neoplasms 4Lung Neoplasms 3Sarcoma, Ewing 2Neoplasm Metastasis 2Ganglioneuroblastoma 2Uterine Cervical Neoplasms 1SCLC 1Rhabdoid Tumor 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Osteosarcoma 1Neuroblastoma 1Fallopian Tube Mucinous Adenocarcinoma 1Extensive Stage Small Cell Lung Cancer (ES-SCLC) 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Neuroendocrine 1

Interventions

Biopsy 5X-Rays 4Specimen Handling 4Phantoms, Imaging 4Nuclear Medicine Department, Hospital 4Magnetic Resonance Spectroscopy 4larotrectinib 2erdafitinib 2ensartinib 2ulixertinib 1tipifarnib 1tazemetostat 1selpercatinib 1palbociclib 1olaparib 1niraparib 1ivosidenib 1elacestrant 1cabozantinib 1alectinib 1abemaciclib 1Vincristine 1Vinblastine 1Vemurafenib 1Topotecan 1Temozolomide 1RAD1901 1Methotrexate 1LY3023414 1Induction Chemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × Topotecan × 30 days × Clear all
NCT00602667 2026-05-19

Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
293 enrolled 89 charts
CNS

Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡